Asset Planning Inc’s Novartis NVS Stock Holding History

Bought
Maintained
Sold
Quarter Market Value Status Shares Change in
Stake
Trade Value Portfolio Weight Portfolio Position
2026
Q2
$16.7K Hold
107
0.01% 224
2026
Q1
$16.3K Hold
107
0.01% 213
2025
Q4
$14.7K Hold
107
0.01% 218
2025
Q3
$13.7K Hold
107
0.01% 226
2025
Q2
$12.9K Hold
107
0.01% 222
2025
Q1
$11.9K Hold
107
0.01% 231
2024
Q4
$10.4K Buy
+107
New +$11.4K 0.01% 241

Other funds holding NVS

Asset Planning Inc's NVS Position: Q2 2026 in Review

Asset Planning Inc held its Novartis (NVS) position steady in Q2 2026 at 107 shares worth $16.7K. The position accounts for 0.01% of the portfolio, ranked #224.

Asset Planning Inc first reported a position in NVS in Q4 2024 and has held it in 7 quarters since. 1,620 funds tracked by Wall St. Rank hold NVS as of Q2 2026.

  • Asset Planning Inc held 107 shares of Novartis worth $16.7K as of Q2 2026.
  • Asset Planning Inc left its Novartis share count unchanged in Q2 2026.
  • Novartis made up 0.01% of Asset Planning Inc's portfolio in Q2 2026, its #224 holding.
  • Asset Planning Inc first reported a position in Novartis in Q4 2024 and has held it in 7 quarters since.
  • 1,620 funds tracked by Wall St. Rank held Novartis as of Q2 2026.

Based on Asset Planning Inc's 13F filing for Q2 2026, filed 27 Jul 2026.